PACT Network
The Pulmonary Fibrosis Australasian Clinical Trials (PACT) network is a component of the CRE-PF supporting pulmonary fibrosis clinical trials in Australasia.
The PACT network is led by A/Prof Ian Glaspole.
The vision of PACT is to reduce the morbidity and mortality associated with pulmonary fibrosis and improve the quality of life for people living with pulmonary fibrosis, their carers and families in Australasia through the facilitation and coordination of high-quality clinical research.
PACT supports randomised, controlled clinical trials to evaluate existing or new medications, combinations of medications, and defined management strategies for patients with pulmonary fibrosis.
PACT aims to:
- Support investigator-driven pulmonary fibrosis research through peer review, facilitate collaboration and streamline HREC/governance approval processes.
- Engage with consumers to improve access to current information and increase awareness about pulmonary fibrosis clinical research in Australasia.
- Support pharma-sponsored pulmonary fibrosis research though: advocating for pulmonary fibrosis research to be conducted in Australasia; assisting sponsors/CROs in identifying suitable sites.
- Advocate for and actively disseminate research outcomes and translate research into practice.
For more information about PACT, pulmonary fibrosis clinical trials in general and to search for pulmonary fibrosis clinical trials currently recruiting, please visit the PACT website.